Seeing Is Believing
AVTX is currently covered by 2 analysts with an average price target of $3689.31. This is a potential upside of $3672 (21213.17%) from yesterday's end of day stock price of $17.31.
Avalo Therapeutics's activity chart (see below) currently has 9 price targets and 18 ratings on display. The stock rating distribution of AVTX is 25% HOLD and 75% BUY.
Analysts average stock forecasts to be materialized ratio is 29.17% with an average time for these price targets to be met of 2.75 days.
Highest price target for AVTX is $16, Lowest price target is $4.
Most recent stock forecast was given by LELAND GERSHELL from OPPENHEIMER on 27-Jun-2023. First documented stock forecast 01-Apr-2019.
Currently out of the existing stock ratings of AVTX, 1 are a HOLD (25%), 3 are a BUY (75%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 27-Jun-2023
$2400
2 years 8 months 8 days ago
(27-Jun-2023)
1/2 (50%)
$909.6 (61.03%)
1
Hold Since 26-Jun-2023
$180
$162.5 (928.57%)
2 years 8 months 9 days ago
(26-Jun-2023)
0/2 (0%)
$60 (50.00%)
Hold Since 03-Mar-2022
$720
$702.5 (4014.29%)
$2160
3 years 27 days ago
(08-Feb-2023)
2/3 (66.67%)
$-48 (-6.25%)
10
Buy Since 01-Apr-2019
$31680
6 years 3 months 5 days ago
(02-Dec-2019)
0/1 (0%)
$13766.4 (76.85%)
What is AVTX (Avalo Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on AVTX (Avalo Therapeutics) with a proven track record?
Which analyst has the current lower performing score on AVTX (Avalo Therapeutics) with a proven track record?
Which analyst has the most public recommendations on AVTX (Avalo Therapeutics)?
Which analyst is the currently most bullish on AVTX (Avalo Therapeutics)?
Which analyst is the currently most reserved on AVTX (Avalo Therapeutics)?